Myelodysplasia-like syndrome and end-stage liver disease - Report of 2 cases

被引：1
|
作者：
Keung, YK
Morgan, D
Hodges, D
Blann, M
Cobos, E
机构：
[1] Texas Tech Univ, Hlth Sci Ctr, Div Hematol Oncol, Lubbock, TX 79430 USA
[2] Texas Tech Univ, Hlth Sci Ctr, Div Gastroenterol, Dept Internal Med, Lubbock, TX 79430 USA
[3] Texas Tech Univ, Hlth Sci Ctr, Dept Pathol, Lubbock, TX 79430 USA
来源：
ACTA HAEMATOLOGICA | 2001年 / 105卷 / 02期
关键词：
alpha(1)-antitrypsin deficiency; cirrhosis; myelodysplastic syndrome; primary biliary cirrhosis;
D O I：
10.1159/000046543
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
We report 2 cases of myelodysplastic syndrome associated with cirrhosis caused by primary biliary cirrhosis and al-antitrypsin deficiency. The etiology of myelodysplasia and its implication in liver transplantation is discussed. Copyright (C) 2001 S. Karger AG, Basel.
引用
收藏
页码：100 / 102
页数：3
相关论文
共 50 条
  • [21] Palliative Care for Patients with End-Stage Liver Disease
    Philips, Cyriac A.
    Kedarisetty, Chandan K.
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2023, 13 (02) : 319 - 328
  • [22] Cardiac Surgery in Patients With End-Stage Liver Disease
    Diaz, Geraldine C.
    Renz, John F.
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2014, 28 (01) : 155 - 162
  • [23] Utility of Modeling End-Stage Liver Disease in Children with Chronic Liver Disease
    Kianifar, Hamidreza
    Fakhari, Sanaz Jafarzadeh
    Khalesi, Maryam
    Kiani, Mohammad Ali
    Ezzati, Atefeh
    Jafari, Seyed Ali
    INTERNATIONAL JOURNAL OF PEDIATRICS-MASHHAD, 2014, 2 (01): : 71 - 74
  • [24] Emerging drugs for complications of end-stage liver disease
    Dowman, Joanna K.
    Holt, Andrew P.
    Newsome, Philip N.
    Adams, David H.
    EXPERT OPINION ON EMERGING DRUGS, 2008, 13 (01) : 159 - 174
  • [25] The painful reality of end-stage liver disease in NASH
    Ratziu, Vlad
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2018, 3 (01): : 8 - 10
  • [26] Osmotic demyelination syndrome: are patients with end-stage liver disease a special risk group?
    Verbeek, Thomas A.
    Stine, Jonathan G.
    Saner, Fuat H.
    Bezinover, Dmitri
    MINERVA ANESTESIOLOGICA, 2020, 86 (07) : 756 - 767
  • [27] Markers of bacterial translocation in end-stage liver disease
    Ioannis Koutsounas
    Garyfallia Kaltsa
    Spyros I Siakavellas
    Giorgos Bamias
    World Journal of Hepatology, 2015, (20) : 2264 - 2273
  • [28] Fractional Flow Reserve in End-Stage Liver Disease
    Kumar, Preetham
    Kim, Juka S.
    Gordin, Jonathan
    Honda, Henry M.
    Suh, William
    Lee, Michael S.
    Press, Marcella
    Nsair, Ali
    Aksoy, Olcay
    Busuttil, Ronald W.
    Tobis, Jonathan
    Parikh, Rushi, V
    AMERICAN JOURNAL OF CARDIOLOGY, 2022, 166 : 122 - 126
  • [29] Integration of Palliative Care in End-Stage Liver Disease and Liver Transplantation
    Potosek, Jamie
    Curry, Michael
    Buss, Mary
    Chittenden, Eva
    JOURNAL OF PALLIATIVE MEDICINE, 2014, 17 (11) : 1271 - 1277
  • [30] Monitoring and Treatment of Coagulation Disorders in End-Stage Liver Disease
    Saner, Fuat H.
    Kirchner, Carmen
    VISCERAL MEDICINE, 2016, 32 (04) : 241 - 248
12345